CD44 as a marker for HIV infection

Details CD44 as a marker for HIV infection CD44 as a marker for HIV infection

1990-03-26

1992-04-28

Nucker, Christine

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 5, 435 71, 435 72, G01N 33533

Patent

active

051089041

ABSTRACT:
A method for discriminating between patients who are seropositive but asymptomatic for HIV infection and AIDS patients is disclosed wherein the fluorescence intensity from CD.sub.44.sup.+ T cells is measured. Intensity increases as AIDS progresses.

REFERENCES:
patent: 3826364 (1974-07-01), Bonner
patent: 4284412 (1981-08-01), Hansen
patent: 4452773 (1984-05-01), Molday
patent: 4520110 (1985-05-01), Stryer
patent: 4607007 (1986-08-01), Lanier et al.
patent: 4661913 (1987-04-01), Wu
patent: 4727020 (1988-02-01), Recktenwald
patent: 5002873 (1991-03-01), St. John et al.
Redfield et al., Sci. Amer., 259 70 (1988).
Weber et al., Sci. Amer., 259:80 (1988).
Leukocyte Typing IV, pp. 619-27 (1989).
Kohler et al., Nature 276 269 (1978).
Herzenberg et al., Sci. Amer. 234 108 (1976).

Affiliated with

Also associated with

Rating

CD44 as a marker for HIV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CD44 as a marker for HIV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD44 as a marker for HIV infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1248828